Live feed
Filing
SC 13G
SC 13G0001493152-20-014963·Ayrton Capital LLC
Schedule 13G ownership disclosure
Sunesis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 867328700
Event date: 2020-07-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-014963
- Form type
- SC 13G
- Filer
- Ayrton Capital LLC
- CIK
- CIK 1698148
- Filed
- Aug 07, 2020
- Reporting period
- Jul 29, 2020
- Description
- Schedule 13G beneficial ownership